Capital International Sarl’s Zimmer Biomet ZBH Stock Holding History

Capital International Sarl’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.62M	Sell	42,034 -376	-0.9%	-$33K	0.05%	169
2026 Q1	$3.83M	Buy	42,410 +3,899	+10%	+$358K	0.06%	165
2025 Q4	$3.46M	Buy	38,511 +398	+1%	+$37.7K	0.06%	169
2025 Q3	$3.75M	Buy	38,113 +3,465	+10%	+$343K	0.06%	161
2025 Q2	$3.16M	Buy	+34,648	New	+$3.35M	0.06%	170
2022 Q2	–	Sell	-28,594	Closed	-$3.66M	–	258
2022 Q1	$3.66M	Buy	28,594 +2,118	+8%	+$255K	0.18%	136
2021 Q4	$3.27M	Buy	26,476 +2,114	+9%	+$277K	0.16%	149
2021 Q3	$3.46M	Buy	24,362 +1,764	+8%	+$259K	0.31%	97
2021 Q2	$3.53M	Sell	22,598 -86	-0.4%	-$13.9K	0.3%	95
2021 Q1	$3.52M	Buy	22,684 +262	+1%	+$40.6K	0.34%	89
2020 Q4	$3.35M	Buy	22,422 +19,421	+647%	+$2.74M	0.35%	86
2020 Q3	$397K	Hold	3,001	–	–	0.05%	190
2020 Q2	$348K	Buy	+3,001	New	+$346K	0.05%	189

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Sarl's ZBH Position: Q2 2026 in Review

Capital International Sarl reduced its Zimmer Biomet (ZBH) stake by 0.89% in Q2 2026, selling an estimated $33K and leaving 42,034 shares worth $3.62M. The position accounts for 0.05% of the portfolio, ranked #169.

Capital International Sarl first reported a position in ZBH in Q2 2020 and has held it in 13 quarters since. The position peaked at $3.83M in Q1 2026. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Capital International Sarl held 42,034 shares of Zimmer Biomet worth $3.62M as of Q2 2026.
Capital International Sarl sold 376 Zimmer Biomet shares in Q2 2026, an estimated $33K.
Zimmer Biomet made up 0.05% of Capital International Sarl's portfolio in Q2 2026, its #169 holding.
Capital International Sarl first reported a position in Zimmer Biomet in Q2 2020 and has held it in 13 quarters since.
Capital International Sarl's Zimmer Biomet position peaked at $3.83M in Q1 2026.
906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.